Look Who’s Coming To RESI on MaRS

Featured Posts

• Just Released: Redefining Early Stage Investments (RESI) Conference Program Guide See What Global Life Science Investors Are Up To

  By Nono Hu, Director of Marketing, LSN It’s 5 days to go until RESI Boston, and LSN would like to present the RESI Program Guide. If you’d like to check out RESI Boston’s full lineup of speakers, sponsors, exhibitors, and innovators, you can read the program guide online now. With nineteen panel discussions, five entrepreneur workshops, dozens […]

• Hot Investor Mandate 20: Southeast Family Office Looks US-Wide for Medtech Deals

  A family office based in the southeast USA focuses its investment interests in healthcare, real estate, energy, and IT. The firm makes equity investments ranging from early-stage to full on commercialization, but also provides debt and convertible loan financing. The firm generally looks for USA-based opportunities but may consider deals outside of the USA and […]

• Hot Investor Mandate 19: Canada VC Invests in Biotech, Medtech and Green Technology

  A venture capital firm based in Canada provides equity capital to portfolio companies and is very flexible in the size of investments it makes, placing a high emphasis on innovation of potential portfolio companies. The firm is currently investing in Canadian companies only, with no set limit on the amount of funds or number of […]

• Hot Investor Mandate 18: Family Office Invests Early in Novel Therapeutics, Devices and Life Science Tools

  A family office based in California invests in primarily early-stage (seed, Series A) companies with truly innovative technologies with a typical investment size of $2-5M per company and can invest as low as $500K. The firm will generally lead investments, and invests globally with no geographic preference. The firm is seeking innovative technology that is […]

• Hot Investor Mandate 17: Hospital Network Fund Invests in Innovative Medical Technologies

  A $150 million venture capital fund managed on behalf of a not-for-profit health system makes direct investments in innovative healthcare companies. Typical equity allocations range from $5-8 million over the life of a company. The firm typically co-invests with other VC funds but is also open to leading in a financing round. The firm is […]